PMID- 28629736 OWN - NLM STAT- MEDLINE DCOM- 20180405 LR - 20181202 IS - 1879-0712 (Electronic) IS - 0014-2999 (Linking) VI - 810 DP - 2017 Sep 5 TI - KFP-H008 blocks gastric acid secretion through inhibiting H(+)-K(+)-ATPase. PG - 112-119 LID - S0014-2999(17)30428-4 [pii] LID - 10.1016/j.ejphar.2017.06.020 [doi] AB - 1-(5-(1H-indol-5-yl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (KFP-H008),a novel and potent potassium-competitive acid blocker for the treatment of acid secretion related diseases, has not been reported previously. In this study, we demonstrated that KFP-H008 inhibits basal acid secretion, 2-deoxy-D-glucose- (2DG-) stimulated gastric acid secretion in rats. KFP-H008 blocked histamine-stimulated acid secretion in rats and heidenhain pouch dogs and reversed acid output in isolated gastric perfusion under histamine stimulation. In all the animal experiments, KFP-H008 exerted a more effective, potent and longer-lasting inhibitory action in comparison with lansoprazole, a proton pump inhibitor (PPI) commonly used in clinic. KFP-H008 inhibited H(+)-K(+)-ATPase activity both at pH 6.5 and pH 7.5, and was unaffected by pH. The inhibitory action was reversible and was achieved in a K(+)-competitive manner. Furthermore, KFP-H008 did not affect Na(+)-K(+)-ATPase activity, thus exhibiting high selectivity, which is different from PPIs. In all, KFP-H008, a novel potassium-competitive acid blocker, may provide new option for the patients with acid-related diseases and provide longer-lasting inhibitory action than drugs commonly used in clinical treatment. CI - Copyright (c) 2017 Elsevier B.V. All rights reserved. FAU - Li, Cheng-Yuan AU - Li CY AD - State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. FAU - Su, Mei AU - Su M AD - State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. FAU - Yan, Yun-Yi AU - Yan YY AD - State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. FAU - Zhou, Lin AU - Zhou L AD - State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. FAU - Ao, Lu-Yao AU - Ao LY AD - State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. FAU - Fang, Wei-Rong AU - Fang WR AD - State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address: weirongfang@163.com. FAU - Li, Yun-Man AU - Li YM AD - State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address: yunmanlicpu@hotmail.com. LA - eng PT - Journal Article DEP - 20170616 PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (1-(5-(1H-indol-5-yl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine) RN - 0 (Indoles) RN - 0 (Proton Pump Inhibitors) RN - 0 (Pyridines) RN - 0 (Pyrroles) RN - 820484N8I3 (Histamine) RN - EC 3.6.3.10 (H(+)-K(+)-Exchanging ATPase) RN - RWP5GA015D (Potassium) SB - IM MH - Animals MH - Gastric Acid/*metabolism MH - H(+)-K(+)-Exchanging ATPase/*metabolism MH - Histamine/pharmacology MH - Indoles/*pharmacology MH - Male MH - Potassium/metabolism MH - Proton Pump Inhibitors/*pharmacology MH - Pyridines/*pharmacology MH - Pyrroles/*pharmacology MH - Rats MH - Rats, Sprague-Dawley OTO - NOTNLM OT - Gastric acid secretion OT - H(+)-K(+)-ATPase OT - Potassium-competitive acid blocker OT - Proton pump inhibitor EDAT- 2017/06/21 06:00 MHDA- 2018/04/06 06:00 CRDT- 2017/06/21 06:00 PHST- 2017/02/27 00:00 [received] PHST- 2017/06/14 00:00 [revised] PHST- 2017/06/15 00:00 [accepted] PHST- 2017/06/21 06:00 [pubmed] PHST- 2018/04/06 06:00 [medline] PHST- 2017/06/21 06:00 [entrez] AID - S0014-2999(17)30428-4 [pii] AID - 10.1016/j.ejphar.2017.06.020 [doi] PST - ppublish SO - Eur J Pharmacol. 2017 Sep 5;810:112-119. doi: 10.1016/j.ejphar.2017.06.020. Epub 2017 Jun 16.